GMAB — Genmab A/S
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Genmab A/S (GMAB), worth $100.77M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $96.64M | 0.13% | -20.3% |
| Quadrature | $2.16M | 0.02% | +135.2% |
| IMC | $1.97M | 0.02% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.